The Parion Sciences CLEAN-PCD study is a phase 2a, 2-part, randomized, double-blind, placebo-controlled study that will evaluate the safety and efficacy of VX-371 solution with and without oral ivacaftor in patients with primary ciliary dyskinesia (PCD). Male and female patients 12 years of age or older with a confirmed diagnosis of PCD may be eligible to participate in this study.
Palmetto Health/USC Department of Pediatrics
Division of Pediatric Pulmonology
9 Richland Medical Park
Columbia, SC 29203
Study Site Principal Investigator Contact Information:
David E. "Trey" Brown, MD at 803-434-7950